Results demonstrated that those children who progressed to type 1 diabetes had a dominant IgG1, whereas IgG3 antibodies were more prevalent before the initiation of exogenous insulin therapy [15], [16]. The gene discussed is INS; the disease is type 1 diabetes mellitus.